PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Ningbo Ergovida Health Technology Ltd.

USPTO PatentsView assignee record - 13 granted patents across 1 technology areas, active 2021–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F16M (FRAMES, CASINGS OR BEDS OF ENGINES, MACHINES OR APPARATUS, NOT SPECIFIC TO ENGINES, MACHINES OR APPARATUS PROVIDED FOR ELSEWHERE; STANDS; SUPPORTS).

Explore the portfolio See the ranking
13
Total patents granted
1
CPC technology areas
1.4
Avg claims per patent
-
5-year filing velocity

The verdict

Ningbo holds 13 US patents across 1 technology areas, rank #21,499 of 50,000 tracked assignees.

#21,499
of 50,000 US assignees by volume
Top 86%
by Innovation Score (24.1/100)
1.4
avg claims per patent

Portfolio overview

Ningbo Ergovida Health Technology Ltd. has been granted 13 US utility patents between 2021 and 2023, placing Ningbo Ergovida Health Technology Ltd. at rank #21,499 across all assignees tracked by PlainPatent. This portfolio spans 1 distinct Cooperative Patent Classification (CPC) subclasses, averaging 1.4 claims per patent with primary concentration in F16M (FRAMES, CASINGS OR BEDS OF ENGINES, MACHINES OR APPARATUS, NOT SPECIFIC TO ENGINES, MACHINES OR APPARATUS PROVIDED FOR ELSEWHERE; STANDS; SUPPORTS). As a Foreign Corporation, Ningbo Ergovida Health Technology Ltd. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 24.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2021 through 2023, with 13 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Ningbo Ergovida Health Technology Ltd.'s 1.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 1 subclass reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ningbo Ergovida Health Technology Ltd. against peers pursuing similar technology classes.

How does Ningbo compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows Ningbo holds 13 patents, placing it at rank #21,499 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Ningbo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

24 Top 86% higher than 14% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). This entry sits in this band. 30–40: 15,294 US assignees (31%). Above this entry. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2023

1234567 202120222023 2
USPTO utility patent grants by year · 2021–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Ningbo Ergovida Health Technology Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 5 38.5%
2022 6 46.2%
2023 2 15.4%

Which technologies does Ningbo Ergovida Health Technology Ltd. patent most?

Top 1 of 1 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple

Where it ranks

Overall rank by patents

#21,499

Across all tracked assignees

Innovation Score

24.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Ningbo Ergovida Health Technology Ltd. hold?
Ningbo Ergovida Health Technology Ltd. holds 13 US granted patents filed between 2021 and 2023, spanning 1 technology areas.
What is Ningbo Ergovida Health Technology Ltd.'s Innovation Score?
Ningbo Ergovida Health Technology Ltd. has an Innovation Score of 24.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Ningbo Ergovida Health Technology Ltd. focus on?
Ningbo Ergovida Health Technology Ltd.'s top technology area is F16M (FRAMES, CASINGS OR BEDS OF ENGINES, MACHINES OR APPARATUS, NOT SPECIFIC TO ENGINES, MACHINES OR APPARATUS PROVIDED FOR ELSEWHERE; STANDS; SUPPORTS) with 1 patents. The company has filed patents in 1 CPC subclasses total.
Is Ningbo Ergovida Health Technology Ltd.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Ningbo Ergovida Health Technology Ltd..
What does claim depth mean for Ningbo Ergovida Health Technology Ltd.'s patents?
Ningbo Ergovida Health Technology Ltd.'s patents average 1.4 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Ningbo Ergovida Health Technology Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

How to use this portfolio

Ningbo's 13 grants land it in the top 86% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Ningbo ranks #21,499 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in F16M - see who else leads that technology area. F16M leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

F16M technology

Ningbo Ergovida Health Technology Ltd.'s primary CPC class, all holders and yearly trends
Top 50 patent holders

See where Ningbo Ergovida Health Technology Ltd. ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.